Jules Bordet Institute: Breast Neoplasms trials

The registry lists 34 Breast Neoplasms studies with Jules Bordet Institute as lead sponsor. 5 are open to participants now and 2 have results posted.

Phase 1 6Phase 2 21No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pregnancy Outcomes After Breast Cancer in Young Women With Germline Pathogenic Variants in Genes Other Than BRCANot yet recruitingNCT07591532
• Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)RecruitingNCT06925984Not applicable
• ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing StudyRecruitingNCT06227338Not applicable
• Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)RecruitingNCT06150898Phase 2
• AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.RecruitingNCT02102165Not applicable
• Safety of Pregnancy in BRCA Mutated Breast Cancer PatientsCompletedNCT03673306Results posted
• Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer PatientsCompletedNCT01420146Phase 1Results posted
• Multidisciplinary Approach to FatigueTerminatedNCT05502224Not applicable
• Evaluation of Neratinib for Treatment and Prevention of Subsequent CNS Event(s) in Patients With Brain Metastasis of Advanced HER2 Positive Breast CancerWithdrawnNCT04856475Phase 2
• De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 BlockadeTerminatedNCT04675827Phase 2
• Neoadjuvant Study of Targeting ROS1 in Combination With Endocrine Therapy in Invasive Lobular Carcinoma of the Breast (ROSALINE)Active, not recruitingNCT04551495Phase 2
• Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:Active, not recruitingNCT03875573Phase 2
• Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBCActive, not recruitingNCT03616886Phase 1/2
• Kadcyla In pAtients With bRAin MetastasisWithdrawnNCT03203616Phase 2
• Neoadjuvant Biomarker ResearcH Study of Palbociclib Combined With Endocrine Therapy in Estrogen Receptor Positive/HER2 Negative Breast CAncer (NeoRHEA)CompletedNCT03065621Phase 2
• Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncerWithdrawnNCT02338531Phase 2
• BIG Molecular Screening Feasibility StudyCompletedNCT02094742Not applicable
• TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free RegimenWithdrawnNCT02053597Phase 2
• Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL WomenCompletedNCT02028364Phase 2
• Study of the ICG Distribution in the Margins of Breast Cancer After TumorectomyCompletedNCT02027818Phase 2
• ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.CompletedNCT01993576Phase 1/2
• Genomic Grade Index (GGI): Feasibility in Routine Practice and Impact on Treatment Decisions in Early Breast CancerCompletedNCT01916837
• Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLCWithdrawnNCT01913067Phase 2
• A Study to Evaluate Denosumab in Young Patients With Primary Breast CancerTerminatedNCT01864798Phase 2
• Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast CancersCompletedNCT01843725Phase 1
• HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1CompletedNCT01565200Phase 2
• Late Cardiac Evaluation of the Three Arm Belgian Trial Involving Node-positive Early Breast Cancer PatientsCompletedNCT01554943Phase 2
• Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast CancerCompletedNCT01537536Phase 2
• Early Cardiac Toxicity of Adjuvant CT in Elderly BC.TerminatedNCT01301040Phase 2
• Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast CancerCompletedNCT00614978Phase 1
• Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast CancerStatus unknownNCT00398437Not applicable
• Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II StudyCompletedNCT00263705Phase 2
• PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2CompletedNCT00199212Phase 1
• Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of EpirubicinTerminatedNCT00162812Phase 2